How to Interpret a Liver Ultrasound Report: Plain Language Guide | ALIV

Liver ultrasound reports are written in language that is perfectly clear to radiologists and entirely opaque to most patients — and even to some non-specialist clinicians. If you have received a report and been left with more questions than answers, this guide decodes the most common terms found in Indian liver ultrasound reports and explains what each finding means practically.

The Most Common Terms Explained

Echogenicity / Increased echogenicity / Hyperechoic liver. Echogenicity refers to how brightly a tissue reflects ultrasound waves. A fatty liver reflects more ultrasound waves than a normal liver — it appears brighter (hyperechoic) on the ultrasound image. "Increased echogenicity" or "hyperechoic echotexture" on a liver ultrasound report is the standard description of hepatic steatosis — fatty liver. The degree of increased echogenicity roughly corresponds to the grade of fatty infiltration. This is the single most common finding in liver ultrasound reports in Indian clinical practice.

Hepatomegaly. Hepatomegaly simply means enlarged liver. The normal liver spans approximately 12–15cm in adults (measured in the mid-clavicular line). Above 15cm is generally reported as hepatomegaly. The causes include fatty infiltration (which causes the liver to swell as its cells fill with fat), viral hepatitis, congestive heart failure, and various infiltrative processes. Mild hepatomegaly is most commonly fatty liver in the urban Indian population.

Coarse echotexture / Heterogeneous echotexture. These terms describe an irregular internal pattern of the liver — as opposed to the normal fine, homogeneous appearance. Coarse or heterogeneous echotexture can suggest: fibrosis or cirrhosis (in which the normal liver architecture is disrupted by scar tissue), chronic hepatitis, or, less commonly, infiltrative processes. This finding warrants further investigation with fibroscan to assess fibrosis stage.

Steatosis / Hepatic steatosis. Steatosis is the medical term for fat accumulation within liver cells. Hepatic steatosis is synonymous with fatty liver. Ultrasound reports may describe "mild/moderate/severe steatosis" — corresponding roughly to Grades 1, 2, and 3 of fatty liver. See our complete grade guide: fatty liver grades 1, 2, and 3 explained.

No focal lesion / No SOL (space-occupying lesion). This is reassuring language — it means the radiologist has not identified any discrete abnormal mass, cyst, or tumour within the liver. A "no focal lesion" finding means the fatty change or other diffuse abnormality is the only finding — which is good news in the context of investigating fatty liver.

Simple hepatic cyst. A fluid-filled, smooth-walled sac within the liver. Simple hepatic cysts are extremely common, almost universally benign, and require no treatment. They are found incidentally in a significant proportion of ultrasound scans. Follow-up is typically recommended only if the cyst is very large (above 5cm) or if there are atypical features suggesting it may not be simple.

Gallbladder findings. Most liver ultrasound reports also assess the gallbladder. Common benign findings include: gallbladder polyps (usually small and benign), gallstones (which may or may not require treatment depending on symptoms), and gallbladder sludge (thickened bile that has not formed true stones). These findings are separate from the liver findings and have their own clinical significance.

What to Ask Your Doctor After Reading the Report

When you receive a liver ultrasound report with abnormal findings, the most useful clinical questions: What is the grade of fatty change? Has fibrosis been assessed (fibroscan)? Are my liver enzymes elevated? What specific dietary and lifestyle changes are most appropriate for my specific findings? How often should I repeat the ultrasound? At ALIV, we review liver ultrasound reports as part of our liver health consultation — providing the plain-language explanation and clinical plan that the report alone cannot supply. Read the complete picture: liver health and fatty liver.

Can a liver ultrasound miss fatty liver?

Yes — particularly Grade 1 (mild) fatty liver. Ultrasound sensitivity for detecting steatosis decreases significantly when fat content is below 20–30% of liver cells. Early Grade 1 fatty liver may not produce sufficient echogenicity change to be reliably detected on ultrasound. MRI-based fat quantification (MRI-PDFF) is more sensitive for early-stage fatty liver but is more expensive and less accessible in routine clinical practice.

What does "liver size within normal limits" mean?

It means the liver measures within the normal reference range for adult size — roughly 12–15cm in the mid-clavicular line. This phrase is the radiologist's way of confirming that the liver is not enlarged (not hepatomegalic), which is a useful piece of negative evidence in the assessment of liver health.

My report says "mild increased echogenicity" — do I need treatment?

This finding is consistent with Grade 1 (mild) fatty liver. At this stage, "treatment" is primarily dietary and lifestyle change — not medication. You do not need pharmacological treatment for mild steatosis in most cases. What you need is a specific, practical dietary plan targeting the metabolic drivers of fatty liver, a follow-up ultrasound at six to twelve months, and a metabolic blood panel to understand the underlying insulin resistance and lipid picture. See: what your fatty liver diagnosis means.

Should I get a fibroscan in addition to a liver ultrasound?

A fibroscan (liver elastography) is appropriate when: you have Grade 2 or 3 fatty liver on ultrasound; your liver enzymes are significantly elevated; you have multiple metabolic risk factors; or your doctor suspects fibrosis may be present alongside the fatty change. For Grade 1 fatty liver with normal enzymes in a young patient with minimal metabolic risk, fibroscan may not be immediately necessary — but discuss the decision with your doctor based on your complete clinical picture.

Can an ultrasound show cirrhosis?

Advanced cirrhosis — with significant scarring, nodular liver surface, portal hypertension, and splenomegaly — is visible on ultrasound. Early fibrosis is not reliably detected by ultrasound. Fibroscan or liver biopsy is required for accurate fibrosis staging in the early-to-moderate range, which is when staging has the most impact on management decisions.